Physiological processes such as ovarian follicle atresia generate large amounts of unnecessary cells or tissue detritus, which needs to be disposed of rapidly. IL-33 is a member of the IL-1 cytokine gene family. Constitutive expression of IL-33 in a wide range of tissues has hinted at its role beyond immune defense. We have previously reported a close correlation between IL-33 expression patterns and ovarian atresia. In this study, we demonstrated that IL-33 is required for disposal of degenerative tissue during ovarian atresia using Il33−/− mice. Deletion of the Il33 gene impaired normal disposal of atretic follicles, resulting in massive accumulations of tissue wastes abundant with aging-related catabolic wastes such as lipofuscin. Accumulation of tissue wastes in Il33−/− mice, in turn, accelerated ovarian aging and functional decline. Thus, their reproductive life span was shortened to two thirds of that for Il33+/− littermates. IL-33 orchestrated disposal mechanism through regulation of autophagy in degenerating tissues and macrophage migration into the tissues. Our study provides direct evidence supporting an expanded role of IL-33 in tissue integrity and aging through regulating disposal of unnecessary tissues or cells.
This article is featured in In This Issue, p.2037
Physiological processes are often accompanied with the generation of tissue detritus or catabolic wastes from unwanted cells or substances. Rapid and proper disposal of these wastes is vital for maintaining tissue integrity and functionality. Accumulation of tissue wastes or catabolic products such as reactive oxidative species and lipofuscin accelerates tissue or cell aging processes (1, 2). Ovaries are active organs. Massive cell death or tissue destruction often follows frequently occurring physiological events. Ovarian atresia, a degenerative process for oocytes, occurs in >99% of follicles (3). Speedy removal of those atretic follicles is crucial for keeping oocytes/follicles healthy. Apoptosis in granulosa cells has been considered the underlying mechanism of atresia (4). However, it remains unclear whether apoptosis occurs in the majority of follicular cells during atresia. Furthermore, it is unknown how this large quantity of degenerative tissue is rapidly removed or disposed of.
IL-33 is a new member of the IL-1 cytokine gene family (5). Because it has a nuclei-binding domain, IL-33 is often detected as a nuclear protein (6). IL-33 has been implicated in regulation of Th2 type T cell response and innate immunity (5, 7). It also functions as an alarmin in defense against viral infection (8). However, mounting evidence suggests its role beyond immune response because of its constitutive expression in many normal tissues (9, 10). We have previously reported IL-33 expression in ovaries (11). The IL-33–expressing cells are largely endothelial cells surrounding developing follicles or in the inner theca of ovulating follicles. IL-33 expression level is closely associated with the estrous cycle and ovulation. Cleaved IL-33 is rapidly released before the wave of atresia and migration of microphages during the estrous cycle. These data suggested its potential roles in these ovarian functions. Using Il33−/− mice, we investigate the involvement of IL-33 during these physiological degenerative processes.
Materials and Methods
Mice and their treatment
C57BL/6 mice were purchased from Harlan (Indianapolis, IN). Il33tm1(KOMP)Vlcg (Il33−/−) mouse strain was created from ES cell clone 12663E-H2 (Regeneron Pharmaceuticals) and made into live mice by the KOMP Repository (https://www.komp.org) and the Mouse Biology Program (http://www.mousebiology.org) at the University of California Davis (12). The strategy for deletion of Il33 gene is shown in Fig. 1A. The mice were maintained in the animal facility at the University of Texas Health Science Center at Houston and allowed to acclimate for a minimum of 7 d. All animal procedures in this study were approved by an institutional animal welfare committee. Ovaries were harvested and fixed in 2% paraformaldehyde or snap-frozen in liquid nitrogen. In some cases, ovaries were used for isolation of total RNA with a kit from Ambion (Austin, TX). For induction of superovulation in mice, a previously published method was adapted (13). In brief, the animals were injected with equine chorionic gonadotropin (Sigma, St. Louis, MO) at 5 IU/mouse i.p. After 48 h, the mice were injected i.p. with human chorionic gonadotropin (hCG), 5 IU/mouse (Sigma).
For genotyping of mice, genomic DNA was isolated from tail tip of the newborn and used for PCR based genotyping. Two pairs of primers for the vector (Neo, 5′-GCAGCCTCTGTTCCACATACACTTCA-3′, and 5′-TCTTCACAGAAAGGGCTGATCTGAGG-3′) and endogenous Il33 gene (Reg-Il33, 5′-CTATGGCCAAATACCCAGCAGAAGC-3′, and 5′-ATGAGAAGTCCCTGGAAGCTAAGGC-3′) were used for PCR (Fig. 1A). PCR was performed for 40 cycles at 94°C for 15 s, 65°C for 40 s, and 72°C for 40 s, which resulted in product DNAs with 653 bp for Neo and 132 bp for Reg-Il33. Typical results for each genotype, that is, Il33+/+, Il33+/−, and Il33−/−, are shown (Fig. 1B). After the animals were used for experiments, their ovaries or other tissues were further used to confirm their genotypes by detection of IL-33 proteins by Western blot or immunofluorescence (11).
Histology, electron microscopy, and detection of lipofuscin
Ovaries or other tissues were fixed in Bouin’s solution for routine H&E staining. Five-micrometer sections were cut through entire ovaries, and three sections with the largest cross sections were used for counting normal or atretic follicles, or corpora lutea. Developing follicles were further classified into type 3 to 8 according to an established method (14). Each type of follicle was separately counted and compared between wild-type (WT) and Il33−/− mice. For transmission electron microscopy, a small piece of ovaries (0.5 mm3) was fixed in 4% of paraformaldehyde and further treated by osmium tetroxide. Ultrathin sections were processed by a routine method for electron microscopic observation. Transmission electron microscopy images were recorded on film or digitally. Two methods were used for detection of ovarian lipofuscin. The first method was Sudan Black B staining following a published method (15). In brief, nonfixed frozen ovarian sections were observed by fluorescent microscope through three channels and autofluorescent images were recorded. The sections were then processed for Sudan Black B staining and observed by the same microscope under bright field. The images from the two were paired and analyzed. The second method was based on the special fluorescent emission peak of lipofuscin. In brief, three UV lasers were used for excitation, and emitting fluorescence spectra (436–714 nm with an average interval of 5 nm) from autofluorescent materials on ovarian sections were recorded with a confocal microscope from Nikon. Emission peaks for lipofuscin were identified following published articles (16, 17).
Long-term fertility trail
One Il33−/− female and one Il33+/− litter mate were housed with a WT fertile male in a cage. Males were rotated every 4 d. Sign of mating (presence of vaginal plug) in each female was examined daily. Upon sign of pregnancy, the female was moved to an isolated cage for delivery. Litter size was recorded immediately after delivery. Mothers were allowed to lactate the neonatal for 3 wk and then were returned to the original cage for mating. If a female failed to become pregnant for 7 wk of continuous mating with multiple males, the mouse was considered infertile. The date for its last delivery was used for calculating reproductive life span. If a female was never able to conceive, the date for starting mating was used for calculation.
Biotin-labeled anti-mouse MHC class II molecules IA/IE (rat IgG2a, 2G9) mAb was purchased from BD Biosciences (San Jose, CA). Biotinylated goat anti-mouse IL-33 Ab and rat anti-mouse IL-33 mAb (clone 396118) were obtained from R&D Systems (Minneapolis, MN) or ProSci (Charleston, SC). FITC-labeled or nonlabeled anti–β-actin Abs and purified anti-ZP3 (IE-10) mAbs were from Sigma-Aldrich. Secondary reagents Alexa 555, Alexa 594, and Alexa 647–labeled (Life Technologies, Carlsbad, CA) and PE-labeled (BD Biosciences) streptavidin were used to visualize biotin-labeled Abs. Biotin/avidin and anti-mouse CD16/32 mAb (D34-485; BD Biosciences) were used for blocking nonspecific IgG binding. Various Ig isotypes used as negative controls were from BD Biosciences.
Immunofluorescence, TUNEL staining, and quantitation of cells on sections
Ovaries, fixed or nonfixed depending on activity of the Abs to be used, were frozen and 3-μm frozen sections were cut. All sections were blocked in 3% BSA with CD16/32 Abs. If biotin-labeled Abs were to be used, a biotin and avidin blocking step was added (Vector BioLab, Philadelphia, PA). The ovarian sections were observed by a fluorescent microscope (Nikon 80i Eclipse; Nikon, Tokyo, Japan) and digital images were captured and analyzed with NIS Elements 3.2 from Nikon. In some cases, fluorescent images were taken by a confocal microscope in M.D. Anderson Cancer Center (Houston, TX). For TUNEL staining, a kit (In Situ Cell Death Detection Kit, Fluorescein; Roche, Nutley, NJ) was used following manufacturer’s instructions. For quantitation of macrophages, six mice were randomly selected from each group, and three frozen sections were randomly cut from each ovary. The ovarian sections were stained by Ab to each macrophage marker together with other Abs. Immunofluorescent images were taken. All atretic developing follicles were identified. The atretic stage of each atretic follicle was determined based on presence of apoptotic cells for early stage and collapsing zona pellucida/deformation for midstage. CD68+ and IA+ macrophages were manually counted for each follicle, respectively. The results were expressed as macrophages/atretic follicle section.
Ovaries were harvested and immediately homogenized on ice in an extraction buffer containing a protease inhibitor mixture (Sigma-Aldrich). After centrifugation at 10,000 × g for 15 min at 4°C, the supernatant was carefully removed and its protein concentration measured. The ovarian extracts were mixed 1:1 with SDS sample buffer. Ten micrograms of protein was loaded on a 12.5% SDS-PAGE and ran at a constant current. After transfer, a membrane (Immobilon-P PVDF; Millipore, Billerica, MA) was used for detection of target proteins. For detection of microtubule-associated protein 1 L chain 3 (LC3), the membrane was simultaneously incubated with biotin-labeled anti-LC3 Ab (rabbit; Novus, Littleton, CO) and anti–β-actin mAb (AC-15; Sigma). The membrane was further incubated with IRDye800CW-labeled anti-rabbit IgG and IRDye 680LT anti-mouse IgG Abs (LI-COR, Lincoln, NE). The membrane was scanned on an infrared fluorescence scanner (Odyssey; LI-COR). A similar method was used for detection of IL-33 proteins.
t tests were used for comparison between two groups. Statistical significances were indicated by *p < 0.05, **p < 0.01, or ***p < 0.001. Before pooling data from multiple groups, data from each experiment were statistically compared to rule out any differences among them. Linear regression test was used for analysis of correlation between ages and ovarian autofluorescence in WT and Il33−/− females, respectively; r2 and p values for deviation from zero were calculated for each progression. Finally, slopes of the two linear progressions were compared for statistical significance.
Deletion of the Il33 gene leads to massive accumulation of abnormally degrading atretic follicles in mouse ovaries
We have reported that a unique spatial and temporal expression pattern of IL-33 in ovaries is closely associated with ovarian atresia surge and ovulation. The sudden release of IL-33 from nuclei prior to atresia surge and ovulation suggests a potential role of IL-33 in these ovarian events (11). To further determine the roles of IL-33, we generated an Il33−/− mutant through deletion of Il33 gene in a C57BL/6 mouse (Fig. 1A, 1B). Characterization of Il33−/− mice demonstrated a complete lack of IL-33 in their ovaries at the protein level by either Western blot or immunofluorescence (Fig. 1C, 1D). No abnormalities were found in the organs of Il33−/− mice at up to ages of 20 wk. Similar to their WT or Il33+/− littermates, female Il33−/− mice matured at 6–8 wk and were initially fertile. However, the presence of large quantities of autofluorescent material in young Il33−/− ovaries was observed (Fig. 2A). The autofluorescence appeared as early as 3–5 wk (puberty), rapidly increased after 5–7 wk (sexually mature), and became massive at 15–20 wk (reproductive peak), which greatly expanded the interstitial tissue (Fig. 2A, 2B). In contrast, WT mice had only a few autofluorescent granules during their reproductive peak (Fig. 2A). The amount of autofluorescence also increased with age in WT mice (Fig. 2B). However, it never reached the level seen in young Il33−/− mice even after 50 wk (Fig. 2B). Linear progression between ovarian autofluorescence and age was analyzed for Il33−/− and WT mice, respectively (Fig. 2B). Statistical comparison between slopes of the two linear progresses showed that Il33−/− ovaries showed a 3.2-fold faster accumulation of autofluorescence than WT ovaries (p < 0.0001; Fig. 2B). The autofluorescence in Il33−/− ovaries was emitted from numerous spherical bodies with diameters of 20–60 μm (Fig. 2C). Ultrastructurally, each spherical body was surrounded by cells resembling theca and contained dislocated degrading organelles, myelin figures (undigested plasma membranes), and granulosa cell nuclei (Fig. 2D). Thus, these autofluorescence-emitting structures were abnormally collapsing atretic follicles. Sudan Black B staining and fluorescent spectra analysis further showed that they were abundant with autofluorescent age pigment lipofuscin (Fig. 2E, 2F). Therefore, deletion of Il33 gene impaired normal disposal of atretic follicles, resulting in accumulation of large amounts of catabolic waste.
Accelerated ovarian function decline and shortened reproductive life in Il33−/− female mice
Catabolic wastes such as lipofuscin have been implicated in tissue aging and degeneration in organs such as eyes and the CNS (18–21). We examined whether the accumulation of wastes from abnormally degrading atretic follicles in Il33−/− mice affected their ovarian functions. Il33−/− mice at their reproductive peak showed significantly fewer total developing follicles and corpora lutea compared with age-matched WT mice (Fig. 3A). The reduction in developing follicles was especially significant for type 3, 4, and 7 follicles (Fig. 3B). Upon equine chorionic gonadotropin/hCG-induced superovulation, the number of eggs ovulated by Il33−/− mice was reduced to 65% of age-matched WT mice, suggesting a significantly shrunken oocyte reservoir (Fig. 3C). A long-term fertility trial under natural mating was performed to assess ovarian aging. The average reproductive life span, as indicated by the age for the last successful delivery, in Il33−/− females was shortened to two thirds of that for Il33+/− littermates (Fig. 3D). Il33−/− females delivered fewer litters than their Il33−/+ littermates (3.15 ± 0.61 versus 5.90 ± 0.48) during their whole reproductive life (Fig. 3E). Thus, accumulation of tissue waste from the impaired disposal of atretic follicles had accelerated ovarian aging, resulting in much earlier cessation of ovarian function.
Failed disposal of atretic follicles is associated with impaired migration of macrophages into atretic follicles
We next investigated why deletion of the Il33 gene impaired disposal of atretic follicles. First, deletion of the Il33 gene did not affect apoptosis during atresia (Fig. 4A, 4C). As we have also previously reported, apoptosis occurs transiently at early atresia and only in a small portion of granulosa cells (11). Based on the earlier results, we concluded that apoptosis is not fully responsible for disposal of atretic follicles. Second, we have reported migration of two subsets of ovarian macrophages into atretic follicles during atresia (11, 22). The first one expresses MHC class II molecule (IA+ macrophages), which invades early atretic follicles with apoptotic cells (Fig. 4A, 4B). The second one, CD68+ macrophages, invades atretic follicles after midatresia postwave of apoptosis; they further move to surround oocytes (Fig. 4C). However, invasion of both IA+ and CD68+ macrophages was not observed in Il33−/− mice (Fig. 4A–D). Instead, autofluorescent materials emerged in follicular cells after midatresia; the autofluorescence first appeared in the cells surrounding oocytes (Fig. 4C). Therefore, development of autofluorescence in atretic follicles in Il33−/− mice was coincident with failed migration of CD68+ macrophages into the same location.
Failed disposal of atretic follicles is associated with diminished autophagy in follicular cells in Il33−/− mice
It is possible that the autofluorescent materials in Il33−/− mice might be remnants of unphagocytized follicular cells because of failed CD68+ macrophage migration. However, it was questionable whether this small number of invading CD68+ macrophages would be able to quickly “clean up” the massive follicular cells. Autophagy is a mechanism that would allow the rapid disposal of unwanted cells (23). Several previous studies have also suggested a potential role of autophagy in ovarian atresia (24, 25). We first determined whether autophagy was involved in normal atresia in WT mice. Three lines of evidence demonstrated that autophagy was a major mechanism for disposal of granulosa cells in atretic follicles. First, LC3 (atg8), a critical molecule in autophagy, must transform from LC3-I to LC3-II to form autophagosomes (26, 27). Western blot of ovarian proteins demonstrated the presence of LC3-II (Fig. 5A). Second, once formed, autophagosomes with LC3 can be detected as subcellular LC3+ granules (28). LC3+ granules were detected in the cytoplasm of granulosa cells only after midatresia (Fig. 5B). This result also showed a co-occurrence of autophagosome formation and invasion of CD68+ macrophages at midstage of atresia (Figs. 4C and 5B). Third, electron microscopy revealed numerous autophagous vacuoles in the granulosa cells of atretic follicles (Fig. 5C, 5D). Autophagosomes characterized by double membranes with organelles inside were also observable (Fig. 5D, inset). However, the occurrence of autophagy was not observed in any stage of atretic follicles of Il33−/− mice. First, ovarian LC3-II was greatly reduced in Il33−/− mice despite a comparable amount of LC3-I with WT mice (Fig. 5A). Second, LC3+ subcellular autophagosomes were not observed in any atretic follicles in Il33−/− mice (Fig. 5B). Failed autophagy in Il33−/− mice was coincident with appearance of autofluorescence. Appearance of autofluorescent lipofuscins, in fact, is a biomarker for declining autophagy (27). Without autophagy and CD68+ macrophages, atretic follicles in Il33−/− simply collapsed. Ultrastructurally, those follicles contained relatively normal but dislocated granulosa cell nuclei and numerous fragmented cytoplasm membranes tangled with degrading organelles. There were no intact plasma membranes and cell boundaries within those collapsing follicles (Fig. 5D). Importantly, autophagous vacuoles were absent in these collapsing follicles (Fig. 5D). We conclude that Il33 gene deletion had impaired autophagy in atretic follicles.
Using Il33−/− mice, we demonstrated that deletion of the Il33 gene impaired the mechanism for disposal of unnecessary tissues, that is, atretic follicles, despite normal apoptosis in follicular cells. As a result, catabolic wastes from abnormally collapsing follicles, such as lipofuscins, accumulated, which, in turn, significantly affected ovarian functions and reproductive life of the host. Regulation of disposal mechanisms for unnecessary cells or tissue catabolic wastes is critical for keeping the integrity and functionality of tissues, especially over a relatively long term. Accumulation of tissue wastes has been considered one of the major factors for exacerbating tissue/cell aging processes (1, 2). Therefore, IL-33 may play a critical role in controlling tissue aging by regulating the disposal of unwanted cells or tissue wastes in the ovaries, although it does not directly participate in any ovarian functions. Potential functions of IL-33 have been explored intensively in the past several years. Those functions include regulation or promotion of Th2 type T cell response, allergic response, and innate immunity (5, 7). IL-33 also acts as an alarmin to enhance CD8+ T cell response during viral infection (8). In contrast with those previous findings, our discovery reveals a unique function of IL-33 in controlling the aging process rather than in immune defense.
The observations from this study, as well as our previous ones, revealed certain sequential events during ovarian atresia: 1) a short, transient period for apoptosis in a small number of follicular cells at early atresia; 2) invasion of MHC class II IA+ macrophages into early atretic follicles; and 3) autophagy in follicular cells, which co-occurred with 4) invasion of CD68+ macrophages at midatresia after transient wave of apoptosis. Deletion of the Il33 gene impaired all events but apoptosis. Impairments in autophagy and CD68+ macrophage migration were coincident with development of autofluorescent materials and abnormal collapse of follicles in Il33−/− mice, suggesting their direct involvement in disposal of atretic follicles. Thus, the earlier results allow us to hypothesize disposal mechanism for atretic follicles after apoptosis as follows: under regulation of IL-33, the majority of follicular cells are first self-digested through autophagy, and the minimal remaining catabolic wastes and tissue debris are then phagocytized by invading CD68+ macrophages. Apoptosis is an early event during atresia for the death in a limited number of granulosa cells, but is not a disposal mechanism for atretic follicles. In addition, the majority of follicular cells do not undergo apoptosis. It is most likely that autophagy is a major pathway for the death of follicular cells.
What is the role of those IA+ macrophages that invade atretic follicles at the early stage, as their invasion is also regulated by IL-33? Unlike CD68+ macrophages, invading IA+ macrophages showed much less phagocytic activity (22). The following reasons suggest that IA+ macrophages, but not IL-33, may induce autophagy in follicular cells during atresia. First, temporally, cleaved IL-33 is released before atresia wave (11). However, autophagy occurs at midatresia and after IA+ macrophage invasion (Fig. 4). Cleaved IL-33 also has a very short half-life (28). The time gap between its release (i.e., before atresia) and initiation of autophagy (i.e., midstage) may not guarantee continued activity of IL-33. Second, spatially, IL-33 is expressed in the endothelia of veins surrounding follicles (11). It would be almost impossible for IL-33 to pass the multiple tissue barriers to reach all follicular cells. Finally, previous studies have shown that autophagy can be induced by macrophage-associated molecules (29). Nevertheless, this hypothesis needs to be proved in the near future. It can be tested by examination of autophagy in macrophage-depleted ovaries. In addition, IL-33 or anti–IL-33 Ab may be specifically delivered to ovaries using liposome bursting technique, which allows us to observe whether the treatment alters IA+ macrophage migration or autophagy in ovaries of WT or Il33−/− mice. Furthermore, we will determine whether autophagy is critical for the disposal of atretic follicles through induction or inhibition of autophagy in granulosa cells with special reagents such as rapamycin (30).
Another potential function of invading IA+ macrophages may be prevention of autoimmunity during tissue death and disposal. During disposal of unwanted follicles, leakage of a large quantity of autoantigens is almost guaranteed. Thus, a tolerance mechanism must exist to prevent or inhibit activation of autoreactive T or B cells. Because atresia is an often occurring physiological process and an unusually large amount of autoantigens is released, this tolerance mechanism is most likely unique and different from those related to stress response systems and disease tolerance during infection, or pathological tissue damage. These follicle-invading IA+ macrophages express a high level of MHC class II, and thus are expected to be excellent APCs. They will surely pick up leaking autoantigens from atretic follicles and present them on MHC class II molecules. It is conceivable, however, that the presentation of those autoantigens must not lead to the activation of autoreactive T cells or B cells. Tolerogenic macrophages or dendritic cells have been well described (31, 32). Thus, it is highly possible that these IA+ macrophages function as one type of tolerogenic APC. They may bring the leaked Ag from atretic follicles and migrate to regional lymph nodes, where they further selectively inactivate or eliminate the autoreactive T or B cells, which recognize the presented autoantigens. Thus, no autoimmunity against ovarian Ags will be provoked during atresia.
It is a common question for all conventional gene knockout animal models that altered phenotypes may be a result of systemic effect of defected genes. However, several results suggest that failed disposal of atretic follicles in our Il33−/− mice is not caused by the systemic effect of IL33 deficiency for the following reasons: First, atresia is normally initiated in Il33−/− mice as evidenced by the presence of apoptotic follicular cells in both timing and quantity. Importantly, deletion of the Il33 gene did not affect either the estrous cycle or atresia. Second, other ovarian functions such as follicular development, ovulation, and maintenance of pregnancy and lactation were largely normal in Il33−/− mice with exception of accelerated ovarian aging. Thus, IL-33 is not directly involved in those ovarian functions. Third, the endocrine axis is critical for regulation of ovarian functions. We have carefully compared histology of the hypothalamus region of brain and pituitaries of Il33−/− mice immediately after their reproductive life (∼1.1 y) with those of age-matched Il33−/− littermates. However, no morphological abnormalities were found in Il33−/− mice. Although it is unlikely that accelerated aging in Il33−/− mice was caused by disturbed endocrine axis, it is necessary to further conduct functional studies to verify our hypothesis in the future. These experiments will include comparisons of pituitary-related hormone level time course or comparison of different groups of pituitary cells through differential staining between WT and Il33−/− mice. Nevertheless, ultimate evidence for the direct role of IL-33 in disposal of atretic follicles should be from an animal model with disturbed IL-33 expression or defected autophagy only in ovaries. Alternatively, we may conditionally knock out Il33 gene or autophagy-related gene in granulosa cells. This is one of our goals in the near future. Finally, it will be important to explore IL-33Rs in ovaries, which is critical for understanding the IL-33–regulated disposal mechanisms. ST2 has been identified as the IL-33R (7, 8). We have previously reported elevated ST2 mRNA level, together with transitional expression of IL-33 during ovulation (11). Our preliminary study showed that ST2 was not expressed by IA+ or CD68+ macrophages. We are currently investigating which ovarian cells express ST2, because this will be the first critical step to understand IL-33–mediated signal pathways.
An IL-33–regulated autophagy-macrophage mechanism is required for disposal of degenerative tissues in ovaries to maintain ovarian tissue integrity and to decelerate its aging process. The significances of our finding should be highlighted. First, our discovery contributes to a fuller understanding of ovarian atresia. Second, the disposal mechanism described in this article may be used to explain several idiopathic human ovarian disorders such as premature ovarian failure and premature ovarian aging. These disorders are common causes of female infertility, and are characterized by accelerated tissue aging and cessation of ovarian function at a young age with unknown cause in >65% of cases (33). It will be interesting to see whether these idiopathic cases are related to deficiencies in disposal mechanisms. Third, our discovery raises a possibility of a similar mechanism in other tissues. Several previous studies have hinted at this possibility. IL-33 is widely expressed in normal tissues including nerve system and cardiovascular system (9, 10, 34, 35). A human genetic study has already linked Il33 gene to neurodegenerative diseases in aged people (36). In addition, impaired autophagy has been implicated in several human age-related degenerative diseases (37, 38). It will be interesting to ask whether IL-33 is also the upstream regulator of autophagy in those organs.
We thank Dr. O. Chunakava for analysis of autofluorescent spectrum, K. Tatum for technical help, and the institutional histology core facility for ovarian histology. Electron microscopy was conducted in Texas Children’s Hospital.
This work was supported by National Institutes of Health Grants R01 HD049613 and R01 DK077857 (to Y.L.). The Il33−/− colony was maintained through institutional bridging funding.
Abbreviations used in this article:
equine chorionic gonadotropin
human chorionic gonadotropin
microtubule-associated protein 1 L chain 3
The authors have no financial conflicts of interest.